Banner Health
People
Chief scientific officer
Senior scientist
Lead investigator
Michael Malek-Ahmadi
Sources: reporter.nih.gov, openalex.org
Trials
Early phase 1, Not yet recruiting, 20 people, Jul 27, 2026
Phase 2/3, Recruiting, 240 people, May 30, 2025
Phase 2/3, Status unknown, 20 people, Mar 26, 2010
Grants and prizes
R01, Alzheimer's Prevention Initiative ADAD Colombia Trial Program, R01AG086363, $351K, 2024–2029, Sep 3, 2026
P30, Arizona Alzheimer's Disease Research Center, P30AG072980, $4.6M, 2021–2031, Aug 31, 2026
R01, Tracer harmonization for amyloid and tau PET imaging using statistical and deep learning techniques, R01AG073424, $708K, 2022–2027, Jul 8, 2026
Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pa (sub-award to BANNER HEALTH), usaspending_subaward/ASST_NON_R01AG096179_075/SB35ENJFKK14, $4.6M, 2026, Feb 3, 2026
Developing a performance-based measure of daily function for screening Hispanic/Latino older adults (sub-award to BANNER HEALTH), usaspending_subaward/ASST_NON_RF1AG091339_075/SB35ENJFKK14, $62.2K, 2025, Dec 31, 2025
R33, Optimizing Research Infrastructure of Registries to Accelerate Participant Recruitment into Alzheimer's Focused Studies, R33AG070604, $759K, 2021–2027, Aug 13, 2025
Alzheimer's Drug Discovery Foundation
Diagnostics Accelerator, Determining %p-tau217 and MTBR-243 by immunoassay, ADDF-22806630, $322K, 2025–2027, Apr 1, 2025
R01, APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease, R01AG069453, $4.9M, 2020–2027, Apr 1, 2025
R01, API A4 Alzheimer's Prevention Trial, R01AG058468, $4.1M, 2018–2025, Mar 11, 2025
R03, Cardiovascular Genotype and APOE ε4 Carrier Status Interaction Effects on Amyloid Load in Pre-Clinical Alzheimer's Disease, R03AG077270, $89.4K, 2023–2026, Mar 4, 2024
R01, Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials, R01AG063954, $1.8M, 2019–2026, Jul 14, 2023
R01, Alzheimer's Prevention Initiative ADAD Colombia Trial, R01AG055444, $5.8M, 2017–2024, Apr 28, 2022
Alzheimer's Disease Research: Standard, Blood Brain Barrier and Metabolism in Aging and AD, A2017272S, $300K, 2017–2021, Jul 1, 2017
Sources: reporter.nih.gov, openalex.org
Named in competing interests
Consulting or advice, Nov 1, 2026
Consulting or advice, Oct 9, 2026
Consulting or advice, Jun 1, 2026
Consulting or advice, May 1, 2026
Patents or royalties, Mar 1, 2026
Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility
Fees or honoraria, Grants or research support, Feb 1, 2026
Cognitive reserve predicts baseline tau burden in the U.S. POINTER trial imaging cohort
Consulting or advice, Nov 1, 2025
Free-water imaging of the nucleus basalis of Meynert in apolipoprotein E4 carriers
Shares or equity, Patents or royalties, Sep 16, 2025
Shares or equity, Patents or royalties, Jul 15, 2025
Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging
Consulting or advice, May 15, 2025
Consulting or advice, Dec 6, 2024
Shares or equity, Patents or royalties, Apr 10, 2023
Employment, May 27, 2020
Sources: europepmc.org, pubmed.ncbi.nlm.nih.gov
Papers
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
Bile Cell-Free DNA as a Liquid Biopsy for Biliary Tract Malignancies: A Scoping Review
Cancers, Oct 27, 2026
ESC Congress 2026 abstract, Oct 26, 2026
Alzheimer’s blood marker varied by race and ethnicity
JAMA neurology, Oct 12, 2026
Cureus, Mar 31, 2026
BMC cardiovascular disorders, Feb 17, 2026
AJPM focus, Feb 2, 2026
Journal of Alzheimer's disease : JAD, Dec 9, 2025
The Journal of arthroplasty, Oct 18, 2025
Free-water imaging of the nucleus basalis of Meynert in apolipoprotein E4 carriers
Frontiers in aging neuroscience, Oct 2, 2025
Journal of neuropsychology, Sep 23, 2025
Journal of aging and physical activity, Oct 7, 2024
Wellcome open research, Sep 24, 2024
World neurosurgery, Mar 8, 2024
The Lancet. Neurology, Dec 16, 2023
Cardiology research, Jan 21, 2023
Geriatrics (Basel, Switzerland), Nov 23, 2022
Atp11b Deletion Affects the Gut Microbiota and Accelerates Brain Aging in Mice
Brain sciences, Jun 25, 2022